Neuma Centre for Social Wellness, Kingston’s first legal psychedelic community health facility, will help administer the ATMA Journey Centers Inc. trial, which is looking to include 500 participants across Canada.Sign up to receive daily headline news from Ottawa Citizen, a division of Postmedia Network Inc.By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc.
ATMA, an Alberta-based company focused on delivering psychedelic-assisted therapy training and conducting psychedelic research, completed the first phase of the psilocybin clinical trial in 2022 to prove the compound’s safety when administered to healthy participants. “ the Ontario partner assisting in the deliverability of the experience for those in Ontario that are looking to go through the trial,” Firth said.
Psilocybin is a naturally occurring compound found in more than 200 species of fungi. Possession, cultivation, sale and transport of mushrooms containing the compound are currently illegal in Canada.Article content In January 2023, the province of Alberta legalized the use of psilocybin and other psychedelics, such as DMT, LSD, MDMA, mescaline and ketamine, for use in psychotherapy. That option is available through psychiatrists licensed and registered in Alberta.
Firth believes careful and intentional psychedelic use could become a meaningful way for people to connect with their own health, wellness and community.
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: GlobalNational - 🏆 81. / 51 Read more »
Source: ottawasuncom - 🏆 4. / 92 Read more »
Source: BNNBloomberg - 🏆 83. / 50 Read more »
Source: GlobalNational - 🏆 81. / 51 Read more »
Source: OttawaCitizen - 🏆 21. / 68 Read more »